Abstract
Colorectal cancer (CRC) is among the leading causes of mortality and morbidity representing a major public health problem. Globally, it is the third most commonly diagnosed cancer in male patients and the second in female ones. Internationally, its incidence is characterized by a wide geographical variation, with almost 55% of the cases being diagnosed in Western countries. In contrast, the incidence and the number of new deaths in Bulgaria, 28.5 and 2,687 (14.04), respectively, are still among the highest in Balkan countries and EU countries as well. Adenocarcinomas originating from epithelial cells of the colorectal mucosa comprise more than 90% of all CRCs. Other types of CRCs include neuroendocrine, squamous cell, adenosquamous, spindle cell, and undifferentiated carcinomas. Recently, the surgical treatment of CRC has made great progress. However, about 50% of patients relapse after treatment, indicating that improving the treatment of CRC with several rehabilitation interventions is still necessary. Rehabilitation is defined as the secret weapon in the holistic management of patients with cancers, aiming to restore mental and/or physical abilities, which might have been lost due to injury or disease, so that the individual is able to lead a normal or near-normal life. Cancer survivors and patients with terminal diseases are highly dependent on rehabilitation in order to optimize quality of life (QoL) and still preserve their dignity. Rehabilitation is an immanent team process that should be integrated throughout the oncology care continuum and delivered by a dedicated physical and rehabilitation medicine (PRM) team. There is an increased demand for a patient-centered approach, tailored to the CRC survivor’s individual needs and wants, which will allow optimal physical, psychological, social, and professional functioning within the limits imposed by cancer and its treatment, as well as maximize the independence and QoL.
Keywords
quality of life, colorectal carcinoma, rehabilitation interventions
References
Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN. Gut. 2022; 72:338–344.
Vekic B, Dragojevic-Simic V, Jakovljevic M, et al. A Correlation Study of the Colorectal Cancer Statistics and Economic Indicators in Selected Balkan Countries. Front Public Health. 2020 Feb 18; 8:29.
Schmidt K, Vogt L, Thiel C, Jäger E, Banzer W. Validity of the six-minute walk test in cancer patients. Int J Sports Med. 2013 Jul;34(7):631-6.
Liu C, Li W, Liu T, et al. Effect of multidisciplinary collaborative empowerment education on psychological distress and quality of life in patients with colorectal cancer undergoing chemotherapy. Support Care Cancer. 2023 Jan 16;31(2):116.